195 related articles for article (PubMed ID: 17064757)
1. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.
Bowen NJ; Logani S; Dickerson EB; Kapa LB; Akhtar M; Benigno BB; McDonald JF
Gynecol Oncol; 2007 Feb; 104(2):331-7. PubMed ID: 17064757
[TBL] [Abstract][Full Text] [Related]
2. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
3. PAX8 expression in ovarian surface epithelial cells.
Adler E; Mhawech-Fauceglia P; Gayther SA; Lawrenson K
Hum Pathol; 2015 Jul; 46(7):948-56. PubMed ID: 26079312
[TBL] [Abstract][Full Text] [Related]
4. Tubal origin of 'ovarian' low-grade serous carcinoma.
Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
[TBL] [Abstract][Full Text] [Related]
5. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
6. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
7. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
Banet N; Kurman RJ
Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
[TBL] [Abstract][Full Text] [Related]
8. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis.
Liliac L; Carcangiu ML; Canevari S; Căruntu ID; Ciobanu Apostol DG; Danciu M; Onofriescu M; Amălinei C
Rom J Morphol Embryol; 2013; 54(1):17-27. PubMed ID: 23529305
[TBL] [Abstract][Full Text] [Related]
9. Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.
Mhawech-Fauceglia P; Wang D; Samrao D; Godoy H; Ough F; Liu S; Pejovic T; Lele S
Gynecol Oncol; 2012 Oct; 127(1):198-201. PubMed ID: 22705448
[TBL] [Abstract][Full Text] [Related]
10. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
11. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
[TBL] [Abstract][Full Text] [Related]
12. The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts.
Gendronneau G; Boucherat O; Aubin J; Lemieux M; Jeannotte L
Endocrinology; 2012 Mar; 153(3):1484-97. PubMed ID: 22315454
[TBL] [Abstract][Full Text] [Related]
13. PAX8, an Emerging Player in Ovarian Cancer.
Gokulnath P; Soriano AA; de Cristofaro T; Di Palma T; Zannini M
Adv Exp Med Biol; 2021; 1330():95-112. PubMed ID: 34339032
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
15. Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.
Shan W; Mercado-Uribe I; Zhang J; Rosen D; Zhang S; Wei J; Liu J
Cell Cycle; 2012 Jun; 11(11):2107-13. PubMed ID: 22592533
[TBL] [Abstract][Full Text] [Related]
16. [Molecular markers derived from ovarian cancer and its correlation with the types of oviductal epithelial lesions].
Yuan Y; Zhu W; Gong G; Jiang J; Wang Y; Wu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 May; 44(5):528-534. PubMed ID: 31303616
[TBL] [Abstract][Full Text] [Related]
17. Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.
DastranjTabrizi A; MostafaGharabaghi P; SheikhzadehHesari F; Sadeghi L; Zamanvandi S; Sarbakhsh P; Ghojazadeh M
Diagn Pathol; 2016 Mar; 11():30. PubMed ID: 27000861
[TBL] [Abstract][Full Text] [Related]
18. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells.
Di Palma T; Lucci V; de Cristofaro T; Filippone MG; Zannini M
BMC Cancer; 2014 Apr; 14():292. PubMed ID: 24766781
[TBL] [Abstract][Full Text] [Related]
19. Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.
Huntsman D; Resau JH; Klineberg E; Auersperg N
Am J Pathol; 1999 Aug; 155(2):343-8. PubMed ID: 10433927
[TBL] [Abstract][Full Text] [Related]
20. PAX8 expression in human bladder cancer.
Pellizzari L; Puppin C; Mariuzzi L; Saro F; Pandolfi M; Di Lauro R; Beltrami CA; Damante G
Oncol Rep; 2006 Nov; 16(5):1015-20. PubMed ID: 17016586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
